Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

CLL Society in the News

CLL Society in the News

Medical and general news reports frequently feature CLL Society as a trusted information source and an authoritative voice of CLL patients’ concerns. When CLL Society surfaces in the news, we share it here.


February 13, 2023

CLL Society’s 2022 Press Release: CLL Society Increases Its Reach, Funds Critical Cancer Research and Advocates for the Immunocompromised in 2022; Starts New Year Poised for Further Growth

For the first time, CLL Society has published a press release reflecting on our significant achievements for the chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL / SLL) community this past year. In 2022, CLL Society took major steps forward in expanding our four pillars: education, support, advocacy, and research.

Read more.

February 2, 2023

USA Today Links the Immunocompromised to CLL Society’s COVID-19 Action Plan

In their 1/28/2023 article: Weak immune system? Government offers advice to help at-risk people avoid COVID-19 infections in the wake of the FDA’s withdrawal of Evusheld’s emergency authorization as it was ineffective for over 90% of the active SARS-CoV-2 variants of concerns, USA Today urges the immunocompromised to have a plan in place and links to CLL Society’s COVID-19 Action Plan as a helpful resource.

Read more.